Article
New York-Eyetech Pharmaceuticals and Archemix Corp. will collaborate on the research and development of aptamers for use in the treatment of ophthalmic diseases.
New miniature telescope for AMD shows promise, raises postoperative concerns
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Treating systemic inflammation may protect against diabetes
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Study finds faricimab effective for nAMD patients unresponsive to other anti-VEGF treatments
Nuance Audio hearing aid glasses receive FDA approval as a medical device